Tagrisso has been recommended as an adjuvant therapy following complete surgical resection in adults with stage 1B to 3A non-small cell lung cancer (NSCLC) whose tumours have epidermal growth ...

Tagrisso has been recommended for use as an adjuvant treatment following complete resection in adults with stage 1B to 3A non-small cell lung cancer (NSCLC) whose tumours express epidermal growth ...

Brain metastases (BMs) are a devastating complication of cancer, occurring ten times more frequently than primary brain ...

AstraZeneca has received two separate recommendations from England’s National Institute for Health and Care Excellence (NICE) for the use of its lung cancer treatments, Tagrisso (osimertinib ...

Alecensa (alectinib) is now an option for patients with stage 1b to 3a ALK-positive NSCLC who have ... In another positive development for the lung cancer community, NICE has also given its ...

Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.

Tagrisso has been recommended as an adjuvant therapy following complete surgical resection in adults with stage 1B to 3A non-small cell lung cancer (NSCLC) whose tumours have epidermal growth factor ...

Greenwood Village resident Heidi Nafman-Onda personally knows the health risks. In 2018, she was diagnosed with stage 3A lung cancer and given a grave diagnosis. "The really scary thing about this was ...

Stage 2 Non-Small Cell Lung Cancer: Overview and More Understanding Stage 3A Non-Small Cell Lung Cancer Stage 3B Non-Small Cell Lung Cancer Treatments and Prognosis A high-energy radiation from X-rays ...

but recent studies have also proved its effect in lung cancer (Yuejing et al., 2014). DNA methyltransferase 3A (DNMT3A) is responsible for the methylation of human genes. DNMT3A gene mutation would ...

The most common form of lung cancer is primarily found in non-smokers, a new study reveals. Doctors react to the surprising driver of the disease and other risk factors.